Strategic Partnerships Opportunity to leverage existing collaborations noted with ALSTEM and Twist Bioscience to expand co-development, licensing, or preferred supplier agreements for CRISPR libraries, DNA synthesis, and sequencing services in broader markets.

Comprehensive DNA Capabilities Position Synbio as a one-stop shop for researchers needing reading, writing, and editing solutions, enabling bundled offerings (oligo synthesis, gene synthesis, subcloning, mutagenesis, CRISPR components, protein expression) to boost average deal size.

Antibody Discovery Focus Capitalize on proprietary antibody discovery workflow (AI-guided pairing, humanization, affinity maturation) to target biotech customers in diagnostics, therapeutics, and biotech tool development seeking accelerated timelines.

Financial Growth Signals Revenue band and recent funding indicate growing market demand; target mid-market research labs and growing startups seeking scalable DNA services and rapid turnaround, offering tiered service levels and volume discounts.

Global Research Enablement With emphasis on global researchers and cost-effective solutions, pursue multi-regional sales outreach, localization, and partnerships to expand adoption in diagnostic probes, vaccine development, and bioprocess applications.